Medsea Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 14 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -2.35%
(FY 2023)
- Profit -26.52%
(FY 2023)
- Ebitda 101.56%
(FY 2023)
- Net Worth -28.66%
(FY 2023)
- Total Assets -13.24%
(FY 2023)
About Medsea Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gulinder Singh and Popinder Kaur serve as directors at the Company.
- CIN/LLPIN
U52100DL2010PTC198999
- Company No.
198999
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Feb 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Medsea Healthcare Private Limited offer?
Medsea Healthcare Private Limited offers a wide range of products and services, including Health Conditions, Bone, Joint & Muscle Care, Vitamins & Supplements, Multivitamins, Sexual Wellness, Men Performance Enhancers.
Who are the key members and board of directors at Medsea Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gulinder Singh  | Director | 11-Feb-2010 | Current |
| Popinder Kaur | Director | Current |
Financial Performance of Medsea Healthcare.
Medsea Healthcare Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.35% decrease. The company also saw a substantial fall in profitability, with a 26.52% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medsea Healthcare?
In 2023, Medsea Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Helios International Healthcare Private LimitedActive 11 years 6 months
Gulinder Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medsea Healthcare?
Medsea Healthcare has a workforce of 1 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medsea Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medsea Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
